antibodi
deriv
import
agent
therapeut
diagnost
even
signific
progress
technolog
antibodi
screen
huge
librari
take
long
time
isol
antibodi
prevent
prompt
action
spread
diseas
report
new
strategi
isol
desir
antibodi
combinatori
librari
one
day
repeat
fluorescenceactiv
cell
sort
fac
first
construct
librari
synthet
human
antibodi
singlechain
variabl
fragment
scfv
express
periplasm
escherichia
coli
label
cell
fluoresc
antigen
probe
highli
fluoresc
cell
sort
use
highspe
cell
sorter
cell
reus
without
regener
next
round
sort
repeat
sort
posit
clone
complet
enrich
sever
hour
thu
screen
librari
three
viral
antigen
includ
influenza
viru
hepat
b
viru
footandmouth
diseas
viru
final
potenti
antibodi
candid
show
k
valu
nm
target
antigen
could
success
isol
even
though
librari
rel
small
result
show
repeat
fac
screen
without
regener
sort
cell
power
method
rapid
respons
spread
diseas
requir
last
two
decad
monoclon
antibodi
antibodi
fragment
proven
effect
therapeut
diagnost
agent
long
invalu
tool
variou
field
biolog
research
develop
antigenspecif
antibodi
hybridoma
technolog
reli
anim
immun
tradit
employ
recent
progress
combinatori
technolog
vitro
antibodi
repertoir
highthroughput
screen
methodolog
allow
develop
targetspecif
antibodi
without
anim
immun
technolog
variou
protein
display
system
includ
phage
display
ribosom
display
cellsurfac
display
wide
use
initi
isol
antibodi
specif
antigen
huge
librari
well
engin
antibodi
toward
desir
function
eg
enhanc
affin
higher
thermost
howev
recent
tool
requir
repeat
screen
order
isol
potenti
candid
librari
consequ
requir
rel
long
time
period
sever
day
week
complet
screen
recent
emerg
rapid
dissemin
new
virus
caus
seriou
human
anim
diseas
sar
coronaviru
swine
flu
viru
avian
influenza
viru
rais
world
concern
develop
new
tool
quickli
isol
antibodi
rapidli
spread
infecti
virus
treatment
well
earli
diagnosi
urgent
requir
current
fluorescenceactiv
cell
sort
fac
use
highthroughput
screen
huge
librari
gener
bigger
cell
construct
variou
display
system
bacteria
yeast
host
follow
strategi
usual
use
screen
recombin
antibodi
librari
cultiv
librari
cell
ii
fluorescentantigenpeptid
protein
label
librari
cell
iii
fac
sort
highli
fluoresc
popul
iv
regener
sort
cell
regrowth
reclon
sort
target
gene
v
repetit
step
iiv
highli
fluoresc
popul
separ
neg
control
popul
vi
analysi
individu
clone
among
step
step
determin
screen
time
regener
sort
cell
step
iv
current
screen
strategi
sort
cell
need
regener
next
round
sort
done
cultiv
cell
least
one
day
reclon
gene
take
sever
day
addit
regener
time
contamin
sort
cell
nonspecif
clone
also
need
consid
cultiv
regener
sort
cell
differenti
growth
rate
among
variou
clone
particularli
nonspecif
clone
due
unregul
protein
express
differ
cell
viabil
decreas
librari
screen
effici
result
round
sort
longer
durat
isol
potenti
antibodi
candid
herein
report
develop
new
highthroughput
screen
strategi
base
escherichia
coli
protein
display
fac
sort
allow
simpl
rapid
isol
potenti
candid
huge
librari
one
day
first
construct
fulli
synthet
human
antibodi
librari
antibodi
fragment
singlechain
variabl
fragment
scfv
produc
periplasm
e
coli
librari
cultiv
permeabil
cell
label
fluoresc
antigen
probe
highli
fluoresc
cell
sort
use
highspe
cell
sorter
immedi
firstround
sort
sort
cell
reus
next
round
sort
without
regener
sort
cell
resort
repeat
highli
fluoresc
popul
becam
enrich
major
popul
use
highspe
fac
sorter
best
candid
could
isol
one
day
overal
strategi
rapid
screen
illustr
figur
proof
concept
success
demonstr
isol
specif
antibodi
fragment
three
model
viral
antigen
influenza
viru
hepat
b
viru
hbv
footandmouth
diseas
viru
fmdv
serotyp
whole
fac
screen
round
synthet
human
antibodi
librari
viral
antigen
could
done
one
day
result
show
repeat
fac
screen
without
regener
sort
cell
rapid
effici
method
isol
potenti
antibodi
candid
case
urgent
requir
bacteri
strain
plasmid
use
studi
list
tabl
e
coli
use
main
host
gene
clone
librari
screen
e
coli
use
product
purif
isol
antibodi
scfv
e
coli
cell
inocul
luriabertani
lb
medium
gl
trypton
gl
yeast
extract
gl
nacl
contain
wv
glucos
overnight
cultiv
rpm
cell
transfer
ml
fresh
lb
medium
without
glucos
flask
incub
rpm
cell
densiti
od
reach
cell
induc
mm
isopropylbdthiogalactopyranosid
iptg
cultiv
rpm
h
cell
harvest
centrifug
rpm
min
analysi
cultiv
ampicillin
mgml
use
sole
antibiot
fac
screen
human
synthet
antibodi
scfv
librari
three
fluoresc
antigen
probe
chemic
synthes
fitccrdnwhgsnrpw
epitop
influenza
viru
ii
fitcnsttfhqalldprvrglyfpagg
epitop
hbv
iii
fitcpvtnvrgdlqvlaqk
epitop
fmdv
one
aliquot
ml
librari
stock
frozen
thaw
inocul
ml
lb
medium
contain
wv
glucos
ampicillin
cultiv
condit
describ
cell
harvest
centrifug
min
rpm
effici
label
fluoresc
probe
cell
pellet
resuspend
triskcl
buffer
mm
trishcl
ph
mm
kcl
dramat
increas
permeabl
e
coli
outer
membran
allow
fluoresc
antigen
probe
permeat
periplasm
resuspend
cell
incub
mm
antigen
peptid
epitop
conjug
fitc
h
cell
wash
twice
buffer
triskcl
fluoresc
probelabel
cell
sort
use
highspe
flow
cytomet
moflo
xdp
beckman
coulter
miami
fl
fac
sort
cell
select
basi
high
fluoresc
intens
detect
bandpass
filter
obtain
fitc
emiss
spectrum
purifi
mode
use
sort
mode
sort
drop
contain
posit
cell
e
coli
cell
sort
round
screen
immedi
reus
next
round
fac
sort
without
regener
sort
repeat
highli
fluoresc
popul
fulli
enrich
obtain
requir
sampl
volum
ml
sheath
buffer
ad
sort
sampl
round
final
sort
scfv
gene
amplifi
sort
cell
perform
pcr
primer
assemblyf
assemblyr
digest
sfii
amplifi
scfv
gene
clone
transform
e
coli
analysi
singl
clone
enrich
cell
produc
flash
tag
flnccpgccmep
nonspecif
cell
cell
harbor
dilut
nonspecif
cell
harbor
ratio
label
mm
flashedt
invitrogen
mix
cell
appli
fac
fluoresc
cell
sort
repeat
fac
screen
describ
product
isol
antibodi
fragment
plasmid
recov
isol
clone
introduc
e
coli
strain
cultiv
ml
lb
medium
cell
harvest
centrifug
min
rpm
cell
wash
twice
pb
resuspend
buffer
crude
extract
cell
prepar
sonic
min
puls
amplitud
extract
centrifug
min
rpm
yield
solubl
lysat
solubl
lysat
filter
syring
filter
solubl
lysat
pour
polyprep
chromatographi
column
biorad
hercul
ca
fill
talon
metalaffin
resin
clontech
mountain
view
ca
resin
wash
twice
ml
wash
buffer
tag
fuse
scfv
elut
use
ml
elut
buffer
purifi
scfv
use
elisa
analysi
prepar
gstfuse
antigen
hbv
fmdv
three
vector
construct
primer
use
construct
gstfuse
antigen
list
tabl
plasmid
contain
gst
gene
use
templat
epitop
sequenc
crdnwhgsnrpw
influenza
viru
fuse
cterminu
gst
perform
pcr
primer
set
gstf
synthesi
epitop
sequenc
nsttfhqalldprvrglyfpagg
hbv
epitop
sequenc
pvtnvrgdlqvlaqk
fmdv
pcr
strategi
use
except
revers
use
synthes
epitop
gene
respect
pcr
product
contain
gstfuse
sequenc
sequenc
epitop
sequenc
digest
use
ndei
hindiii
clone
yield
respect
e
coli
harbor
cultiv
ml
lb
medium
shake
flask
rpm
cell
densiti
od
reach
cell
induc
mm
iptg
cultiv
rpm
h
cell
harvest
centrifug
rpm
min
cell
resuspend
ml
pb
lyse
sonic
min
puls
amplitud
filtrat
syring
filter
sartoriu
stedim
biotech
goettingen
germani
remov
residu
insolubl
debri
gstfuse
antigen
purifi
use
glutathion
sepharos
resin
ge
healthcar
bioscienc
ab
uppsala
sweden
per
method
specifi
manufactur
gstfuse
antigen
mix
carbonatebicarbon
coat
buffer
ph
final
concentr
mm
antigen
solut
ml
load
onto
elisa
plate
incub
h
subsequ
well
wash
four
time
pbst
mm
nacl
mm
kcl
mm
na
hpo
mm
kh
po
ph
fill
ml
bsa
solut
plate
incub
h
wash
pbst
four
time
scfv
sampl
solubl
lysat
purifi
sampl
load
plate
plate
incub
overnight
well
wash
four
time
pbst
monoclon
antihi
antibodi
conjug
horseradish
peroxidas
hrp
sigmaaldrich
st
loui
mo
ad
plate
incub
h
final
well
wash
pbst
tetramethylbenzidien
tmb
ad
colorimetr
detect
bound
scfv
clone
reaction
arrest
ad
h
stop
solut
absorb
measur
nm
use
tecan
infinit
pro
elisa
plate
reader
tecan
group
ltd
nnedorf
switzerland
confirm
bind
activ
scfv
inactiv
whole
fmdv
fmdv
serotyp
kit
priocheck
fmdv
type
prionic
switzerland
use
elisa
perform
manner
except
antigenco
step
protein
sampl
analyz
perform
electrophoresi
wv
sdspolyacrylamid
gel
electrophoresi
sdspage
gel
immunodetect
histagfus
scfv
protein
monoclon
antihi
antibodi
conjug
horseradish
peroxidas
hrp
sigmaaldrich
use
ecl
kit
amersham
ecl
prime
western
blot
detect
reagent
ge
healthcar
use
signal
detect
prove
concept
strategi
repeat
fac
screen
without
regener
fig
first
conduct
enrich
probespecif
cell
mixtur
nonspecif
cell
enrich
experi
flashedt
interact
flash
tag
flnccpgccmep
give
fluoresc
signal
use
probe
cell
label
cell
produc
flashtag
fuse
maltos
bind
protein
mbp
mix
cell
produc
notag
protein
dilut
ratio
enrich
posit
cell
perform
repeat
fac
screen
strategi
mixtur
fluoresc
cell
top
total
popul
sort
immedi
first
round
sort
sort
cell
appli
next
round
sort
fac
without
cell
regener
shown
fig
fluoresc
cell
began
enrich
second
round
fulli
enrich
fourth
round
sort
success
enrich
probespecif
clone
clearli
indic
repeat
fac
screen
strategi
use
rapid
screen
antigenspecif
antibodi
librari
fulli
synthet
human
antibodi
scfv
librari
six
diversifi
complementaritydetermin
region
cdr
construct
detail
procedur
synthet
librari
construct
describ
figur
briefli
follow
kabat
definit
use
databas
human
germlin
gene
http
wwwbioinforgukabysi
singl
chain
variabl
fragment
scfv
design
eight
framework
region
fr
six
cdr
regard
frequenc
usag
express
e
coli
dpk
human
germlin
gene
chosen
framework
region
vh
vl
respect
divers
cdr
loop
except
cdr
degener
oligonucleotid
design
basi
frequenc
amino
acid
site
human
germlin
gene
databas
tabl
case
cdr
much
greater
divers
amino
acid
composit
length
introduc
unlik
case
cdr
use
set
degener
oligonucleotid
nnk
random
sequenc
differ
length
amino
acid
fig
vh
vl
gene
assembl
pcr
elimin
clone
contain
stop
codon
frameshift
vh
vl
gene
pcr
product
vh
vl
clone
blactamas
fusion
system
select
system
e
coli
clone
contain
infram
gene
chain
produc
function
blactamas
fusion
protein
periplasm
select
use
ampicillincontain
agar
plate
select
infram
vh
vl
gene
rescu
gene
sequenc
determin
sequenc
sequenc
experi
found
clone
contain
infram
codon
stop
codon
observ
within
code
gene
data
shown
rescu
vh
gene
vl
gene
link
full
antibodi
fragment
scfv
format
infram
scfv
gene
also
select
blactamas
fusion
system
select
clone
infram
scfv
gene
rescu
clone
construct
synthet
human
antibodi
scfv
librari
librari
clone
randomli
chosen
sequenc
analyz
clearli
confirm
clone
contain
variou
sequenc
cdr
fig
also
randomli
select
clone
show
good
level
scfv
gene
express
e
coli
fig
size
final
construct
librari
suffici
initi
isol
antibodi
candid
target
antigen
synthet
librari
conduct
isol
antibodi
candid
three
antigen
antigen
epitop
influenza
viru
ii
antigen
epitop
hbv
iii
antigen
epitop
fmdv
order
isol
epitopespecif
antibodi
scfv
synthet
librari
screen
shown
figur
cultiv
librari
cell
harvest
treat
triskcl
buffer
improv
permeabl
outer
membran
increas
label
effici
cell
fluoresc
probe
cell
mix
mm
antigen
peptid
conjug
fitc
cell
fluoresc
analyz
fac
compar
neg
control
e
coli
harbor
vector
cell
origin
librari
show
slightli
higher
mostli
similar
fluoresc
intens
fig
origin
librari
fluoresc
cell
top
total
popul
sort
number
sort
event
reach
immedi
first
round
sort
sort
cell
appli
second
round
sort
fac
fluoresc
popul
sort
cell
top
total
popul
sort
repeat
sort
three
time
highli
fluoresc
popul
becam
major
popul
final
th
round
sort
fluoresc
sort
cell
clearli
observ
fulli
separ
origin
black
bar
indic
signal
bsa
coat
well
grey
bar
indic
signal
gstfuse
antigen
coat
well
c
elisa
analysi
purifi
scfv
symbol
circl
squar
triangl
repres
purifi
antibodi
clone
respect
close
open
symbol
repres
coat
gstfuse
antigen
bsa
plate
respect
librari
fig
final
fluoresc
cell
collect
use
analysi
individu
clone
sort
result
summar
tabl
final
screen
scfv
gene
sort
cell
rescu
pcr
pcr
product
clone
periplasm
express
scfv
transform
e
coli
total
coloni
randomli
pick
agar
plate
bind
activ
isol
antibodi
analyz
perform
elisa
clone
except
one
exhibit
higher
bind
activ
peptid
nonspecif
bsa
control
fig
sequenc
experi
found
among
clone
six
clone
includ
dna
sequenc
two
clone
also
clone
anoth
two
clone
clone
sequenc
show
similar
level
bind
activ
except
fig
among
clone
four
includ
show
rel
higher
bind
activ
clone
therefor
tri
purif
scfv
analyz
specif
activ
four
scfv
gene
transform
e
coli
strain
proteasedefici
suitabl
higher
scfv
product
cultiv
scfv
three
clone
could
purifi
high
puriti
fail
purifi
scfv
clone
data
shown
specif
activ
three
purifi
scfv
epitop
analyz
elisa
observ
bind
activ
higher
nonspecif
bsa
control
fig
sequenc
inform
three
isol
scfv
provid
figur
demonstr
gener
use
strategi
antibodi
screen
also
isol
potenti
antibodi
anoth
target
hbv
cultiv
permeabil
librari
cell
label
antigen
peptid
conjug
fitc
label
librari
cell
sort
fac
origin
librari
fluoresc
cell
top
total
popul
sort
number
sort
event
reach
repeat
sort
without
regener
three
time
highli
fluoresc
cell
enrich
major
popul
final
cell
collect
fig
tabl
scfv
gene
final
sort
cell
regener
pcr
clone
transform
e
coli
strain
among
regener
clone
total
coloni
plate
randomli
pick
bind
activ
analyz
elisa
clone
exhibit
good
bind
activ
antigen
hbv
among
clone
four
exhibit
rel
higher
bind
activ
clone
fig
sequenc
experi
confirm
two
clone
ident
three
clone
chosen
analysi
cultiv
antibodi
success
purifi
data
shown
specif
bind
activ
purifi
antibodi
evalu
elisa
observ
scfv
purifi
clone
much
higher
bind
activ
clone
fig
sequenc
inform
three
isol
scfv
provid
figur
footandmouth
diseas
fmd
highli
contagi
viral
diseas
infect
clovenhoof
anim
cattl
swine
result
massiv
livestock
loss
around
world
diagnosi
fmdv
earlystag
contamin
crucial
prevent
contagion
develop
immunodiagnost
system
highli
specif
antibodi
necessari
therefor
chose
antigen
epitop
fmdv
anoth
target
antigen
applic
repeat
fac
screen
system
synthet
antibodi
librari
cell
cultiv
label
fitcconjug
antigen
peptid
label
librari
cell
sort
fac
origin
librari
fluoresc
cell
top
total
popul
sort
number
sort
event
reach
two
round
fac
screen
highli
fluoresc
cell
enrich
major
popul
final
cell
collect
fig
tabl
scfv
gene
final
sort
cell
regener
pcr
clone
transform
e
coli
strain
regener
cell
randomli
pick
clone
obtain
four
clone
express
activ
scfv
antigen
epitop
fig
four
scfv
show
high
bind
purifi
analys
elisa
observ
one
scfv
much
higher
bind
activ
other
fig
final
also
examin
bind
activ
isol
scfv
whole
inactiv
fmdv
clearli
observ
isol
antibodi
fragment
exhibit
high
bind
activ
fmdv
neg
control
scfv
specif
bind
anthrax
toxin
pa
show
neglig
signal
fig
sequenc
inform
four
isol
scfv
provid
figur
bind
affin
isol
antibodi
bind
activ
k
isol
antibodi
antigen
also
determin
spr
analysi
antigen
immobil
chip
purifi
antibodi
load
bind
affin
analyz
bind
affin
k
isol
antibodi
scfv
epitop
scfv
scfv
nm
nm
nm
respect
fig
similar
typic
obtain
use
hybridoma
technolog
antibodi
screen
strategi
includ
phage
display
etc
spr
analysi
affin
overestim
due
avid
effect
dimer
multimer
antibodi
check
presenc
dimer
antibodi
purifi
sampl
purifi
antibodi
analyz
size
exclus
column
chromatographi
sdspage
analysi
nonreduc
reduc
condit
experi
clearli
confirm
purifi
sampl
present
mainli
monomer
form
fig
fig
possibl
avid
effect
spr
analysi
could
exclud
specif
isol
scfv
also
confirm
western
blot
complex
protein
mixtur
contain
wildtyp
gst
antigenfus
gst
shown
figur
scfv
could
bind
specif
viral
antigenfus
gst
solubl
lysat
e
coli
host
taken
data
conclud
screen
antibodi
could
isol
nonspecif
bind
antibodi
cell
surfac
sticki
histogram
origin
librari
st
round
nd
round
sort
cell
repres
red
orang
green
curv
respect
rd
round
sort
cell
use
regener
scfv
gene
pcr
histogram
shown
b
elisa
solubl
lysat
select
clone
black
bar
indic
signal
bsa
coat
well
grey
bar
indic
signal
gstfuse
antigen
coat
well
c
elisa
analysi
purifi
scfv
symbol
circl
squar
triangl
diamond
repres
purifi
antibodi
clone
respect
signal
detect
well
coat
gstfuse
antigen
plate
specif
bind
antibodi
antigen
probe
mean
strategi
valid
rapid
isol
antibodi
librari
screen
librari
construct
anim
immun
mainli
mous
antigen
sever
benefit
mous
antibodi
give
rise
human
antimurin
antibodi
respons
hama
reduc
undesir
immunogen
isol
mous
antibodi
human
procedur
commonli
requir
nonhuman
cdr
conjug
given
human
sequenc
howev
exchang
mous
framework
human
framework
alway
guarante
similar
affin
often
lead
less
immunogen
therefor
suitabl
rapid
isol
effect
antibodi
instead
immun
antibodi
librari
nonimmun
synthet
antibodi
librari
develop
gener
construct
human
antibodi
framework
synthet
librari
qualiti
divers
particular
import
isol
antibodi
therefor
six
complementaritydetermin
region
fulli
random
insert
singl
human
antibodi
framework
effici
solubl
product
antibodi
bacteri
host
well
less
immunogen
human
bodi
choic
framework
librari
construct
also
need
consid
serious
therefor
isol
clone
synthet
librari
like
favor
properti
product
therapeut
applic
within
human
genom
known
v
h
v
l
v
k
gene
segment
exist
although
gene
segment
produc
function
antibodi
level
gene
express
stabil
antibodi
differ
synthet
librari
dpk
human
germlin
gene
highli
preval
human
antibodi
known
well
express
e
coli
chosen
framework
region
vh
vl
respect
result
antibodi
librari
show
divers
size
know
librari
size
rel
small
compar
divers
natur
human
antibodi
repertoir
construct
much
bigger
librari
need
increas
probabl
gener
antibodi
variou
antigen
howev
although
size
librari
larg
qualiti
librari
enough
use
isol
antigenspecif
antibodi
reduc
incid
frame
shift
stop
codon
librari
construct
librari
subject
infram
select
fusion
blactamas
ampicillin
resist
select
qualiti
librari
valid
sequenc
clone
randomli
select
librari
analysi
antibodi
product
e
coli
fig
clone
select
randomli
construct
librari
isol
clone
screen
exhibit
good
express
level
high
solubl
e
coli
therefor
conclud
highqual
human
antibodi
librari
high
divers
six
cdr
success
synthes
suitabl
rapid
isol
antigenspecif
antibodi
isol
highli
potenti
clone
huge
librari
larg
microbi
librari
need
screen
multipl
round
sort
due
contamin
nonspecif
falseposit
clone
howev
strategi
regener
step
take
long
time
make
difficult
rapidli
isol
potenti
antibodi
combinatori
librari
strategi
howev
includ
timelimit
regener
step
sort
popul
sort
popul
use
immedi
next
round
sort
resort
process
repeat
highli
fluoresc
popul
becom
separ
neg
popul
without
regener
step
highli
fluoresc
cell
produc
potenti
antibodi
candid
could
collect
four
hour
repeat
sort
sort
use
highspe
fac
sorter
screen
cell
per
sec
sort
rate
first
round
sort
million
cell
librari
took
approxim
h
repeat
sort
time
could
complet
hour
initi
round
sort
falseposit
clone
fluoresc
antigen
probe
nonspecif
bound
antibodi
cell
found
howev
clone
remov
repeat
sort
due
fact
bind
antigen
probe
strong
maintain
repeat
sort
four
hour
strategi
overal
procedur
cell
cultiv
final
round
sort
could
complet
one
day
much
time
save
unlik
previou
strategi
addit
need
consid
effect
differ
cell
growth
sort
cell
popul
next
round
sort
stress
condit
fac
screen
process
antibodi
express
sever
affect
cell
viabil
therefor
overnight
cultiv
regener
viabl
cell
tend
overgrow
becom
major
popul
simpli
viabil
bind
activ
use
unfavor
popul
next
round
screen
make
difficult
isol
posit
clone
howev
elimin
need
regener
strategi
minim
risk
overgrowth
falseposit
clone
well
lose
posit
candid
sort
process
consequ
antibodi
candid
rapidli
isol
one
day
success
demonstr
three
antigen
model
antigen
epitop
influenza
viru
antigen
epitop
hbv
antigen
epitop
fmdv
isol
antibodi
exhibit
highli
specif
strong
activ
antigen
target
although
could
get
success
screen
result
three
examin
antigen
mean
use
screen
strategi
guarante
success
screen
antibodi
variou
antigen
one
limit
consid
variabl
perform
fac
screen
respect
individu
antigen
due
differ
properti
sticki
size
permeabl
individu
antigen
probe
cell
nonspecif
label
probe
unwant
screen
result
isol
nonspecif
lowaffin
antibodi
obtain
minim
nonspecif
label
probe
may
need
modifi
label
condit
display
system
accord
properti
probe
exampl
current
display
system
big
size
kda
probe
use
screen
enter
periplasm
cell
strategi
suitabl
antibodi
screen
big
size
antigen
includ
whole
viru
accommod
big
size
probe
suggest
use
apex
system
instead
current
periplasm
express
system
apex
system
outer
membran
partial
remov
spheroplast
treatment
allow
entranc
big
size
antigen
periplasm
apex
system
alreadi
demonstr
antibodi
interact
antigen
larg
kda
periplasm
e
coli
strategi
easili
combin
apex
system
use
apex
system
cell
label
big
size
antigen
posit
label
cell
isol
repeat
sort
like
display
system
label
condit
modifi
necessari
isol
posit
clone
done
repeat
sort
strategi
conclus
develop
new
strategi
isol
antigenspecif
antibodi
e
coli
simpli
repeat
fac
use
highspe
cell
sorter
fulli
synthet
human
antibodi
librari
six
diversifi
cdr
construct
e
coli
repeat
sort
potenti
antibodi
candid
three
viral
antigen
influenza
viru
hbv
fmdv
could
success
isol
one
day
isol
antibodi
candid
easili
purifi
high
activ
antigen
confirm
perform
elisa
case
fmdv
final
isol
antibodi
candid
also
reveal
high
affin
antigen
peptid
probe
also
entir
fmdv
therefor
studi
shown
repeat
fac
screen
without
regener
sort
cell
altern
strategi
isol
potenti
antibodi
candid
therapeut
diagnost
use
emerg
screen
strategi
expect
use
situat
requir
rapid
respons
spread
diseas
figur
amino
acid
sequenc
isol
antibodi
three
antigen
scfv
epitop
scfv
epitop
hbv
scfv
fmdv
